Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Net Margin (2017 - 2025)

Historic Net Margin for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 9.63%.

  • Organogenesis Holdings' Net Margin fell 10800.0% to 9.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.88%, marking a year-over-year decrease of 12600.0%. This contributed to the annual value of 0.19% for FY2024, which is 13400.0% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Net Margin stood at 9.63%, which was down 10800.0% from 12.08% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Net Margin ranged from a high of 39.88% in Q4 2021 and a low of 24.91% during Q1 2025
  • Moreover, its 5-year median value for Net Margin was 4.53% (2023), whereas its average is 3.55%.
  • As far as peak fluctuations go, Organogenesis Holdings' Net Margin soared by 361200bps in 2021, and later crashed by -334000bps in 2022.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Net Margin stood at 39.88% in 2021, then tumbled by -84bps to 6.48% in 2022, then crashed by -109bps to 0.57% in 2023, then surged by 914bps to 4.64% in 2024, then skyrocketed by 108bps to 9.63% in 2025.
  • Its Net Margin stands at 9.63% for Q3 2025, versus 12.08% for Q2 2025 and 24.91% for Q1 2025.